STAAR SURGICAL CO Quarterly Revenues in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Staar Surgical Co quarterly/annual Revenues history and growth rate from Q1 2011 to Q3 2024.
  • Staar Surgical Co Revenues for the quarter ending September 27, 2024 was $88.6M, a 10.3% increase year-over-year.
  • Staar Surgical Co Revenues for the twelve months ending September 27, 2024 was $341M, a 10% increase year-over-year.
  • Staar Surgical Co annual Revenues for 2023 was $322M, a 13.4% increase from 2022.
  • Staar Surgical Co annual Revenues for 2022 was $284M, a 23.4% increase from 2021.
  • Staar Surgical Co annual Revenues for 2021 was $230M, a 41% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $341M $88.6M +$8.28M +10.3% Jun 29, 2024 Sep 27, 2024 10-Q 2024-10-30
Q2 2024 $333M $99M +$6.7M +7.26% Mar 30, 2024 Jun 28, 2024 10-Q 2024-08-07
Q1 2024 $326M $77.4M +$3.83M +5.21% Dec 30, 2023 Mar 29, 2024 10-Q 2024-05-07
Q4 2023 $322M $76.3M +$12.2M +19.1% Sep 30, 2023 Dec 29, 2023 10-K 2024-02-27
Q3 2023 $310M $80.3M +$4.26M +5.61% Jul 1, 2023 Sep 29, 2023 10-Q 2024-10-30
Q2 2023 $306M $92.3M +$11.2M +13.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $295M $73.5M +$10.3M +16.3% Dec 31, 2022 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $284M $64M +$5.04M +8.55% Oct 1, 2022 Dec 30, 2022 10-K 2024-02-27
Q3 2022 $279M $76M +$17.7M +30.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $262M $81.1M +$18.7M +30% Apr 2, 2022 Jul 1, 2022 10-Q 2023-08-02
Q1 2022 $243M $63.2M +$12.4M +24.5% Jan 1, 2022 Apr 1, 2022 10-Q 2023-05-03
Q4 2021 $230M $59M +$13M +28.3% Oct 2, 2021 Dec 31, 2021 10-K 2022-02-23
Q3 2021 $217M $58.4M +$11.3M +23.9% Jul 2, 2021 Oct 1, 2021 10-Q 2022-11-02
Q2 2021 $206M $62.4M +$27.2M +77.2% Apr 3, 2021 Jul 2, 2021 10-Q 2022-08-10
Q1 2021 $179M $50.8M +$15.6M +44.2% Jan 2, 2021 Apr 2, 2021 10-Q 2022-05-04
Q4 2020 $163M $46M +$7.12M +18.3% Oct 3, 2020 Jan 1, 2021 10-K 2022-02-23
Q3 2020 $156M $47.1M +$8.03M +20.6% Jul 4, 2020 Oct 2, 2020 10-K 2022-02-23
Q2 2020 $148M $35.2M -$4.47M -11.3% Apr 4, 2020 Jul 3, 2020 10-K 2022-02-23
Q1 2020 $153M $35.2M +$2.6M +7.99% Jan 4, 2020 Apr 3, 2020 10-K 2022-02-23
Q4 2019 $150M $38.9M +$7.7M +24.7% Sep 28, 2019 Jan 3, 2020 10-K 2021-02-24
Q3 2019 $142M $39.1M +$7.29M +22.9% Jun 29, 2019 Sep 27, 2019 10-K 2021-02-24
Q2 2019 $135M $39.7M +$5.76M +17% Mar 30, 2019 Jun 28, 2019 10-K 2021-02-24
Q1 2019 $129M $32.6M +$5.49M +20.3% Dec 29, 2018 Mar 29, 2019 10-K 2021-02-24
Q4 2018 $124M $31.2M +$6.33M +25.5% Sep 29, 2018 Dec 28, 2018 10-K 2020-02-26
Q3 2018 $118M $31.8M +$8.3M +35.3% Jun 30, 2018 Sep 28, 2018 10-K 2020-02-26
Q2 2018 $109M $33.9M +$12M +54.6% Mar 30, 2018 Jun 29, 2018 10-Q 2018-08-01
Q1 2018 $97.4M $27.1M +$6.74M +33.1% Dec 30, 2017 Mar 30, 2018 10-K 2020-02-26
Q4 2017 $90.6M $24.9M +$2.72M +12.3% Sep 30, 2017 Dec 29, 2017 10-K 2019-02-21
Q3 2017 $87.9M $23.5M +$3.42M +17.1% Jul 1, 2017 Sep 29, 2017 10-K 2019-02-21
Q2 2017 $84.5M $21.9M +$962K +4.59% Mar 31, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $83.5M $20.4M +$1.08M +5.61% Dec 31, 2016 Mar 31, 2017 10-K 2018-02-28
Q4 2016 $82.4M $22.1M +$1.28M +6.13% Oct 1, 2016 Dec 30, 2016 10-K 2018-02-28
Q3 2016 $81.2M $20.1M +$1.3M +6.94% Jul 2, 2016 Sep 30, 2016 10-K 2018-02-28
Q2 2016 $79.9M $21M +$2.32M +12.4% Apr 2, 2016 Jul 1, 2016 10-K 2018-02-28
Q1 2016 $77.5M $19.3M +$411K +2.18% Jan 2, 2016 Apr 1, 2016 10-K 2018-02-28
Q4 2015 $77.1M $20.9M +$4.29M +25.9% Oct 3, 2015 Jan 1, 2016 10-K 2017-03-02
Q3 2015 $72.8M $18.8M +$562K +3.09% Jul 4, 2015 Oct 2, 2015 10-K 2017-03-02
Q2 2015 $72.3M $18.7M -$1.39M -6.94% Apr 4, 2015 Jul 3, 2015 10-K 2017-03-02
Q1 2015 $73.7M $18.9M -$1.32M -6.54% Jan 3, 2015 Apr 3, 2015 10-K 2017-03-02
Q4 2014 $75M $16.6M -$2.37M -12.5% Oct 3, 2014 Jan 2, 2015 10-K 2015-03-13
Q3 2014 $77.4M $18.2M +$1.08M +6.33% Jul 3, 2014 Oct 2, 2014 10-K 2015-03-13
Q2 2014 $76.3M $20M +$1.88M +10.4% Apr 3, 2014 Jul 2, 2014 10-K 2015-03-13
Q1 2014 $74.4M $20.2M +$2.18M +12.1% Jan 4, 2014 Apr 2, 2014 10-K 2015-03-13
Q4 2013 $72.2M $18.9M +$2.48M +15% Oct 4, 2013 Jan 2, 2014 10-K 2015-03-13
Q3 2013 $69.7M $17.1M +$1.24M +7.82% Jul 4, 2013 Oct 3, 2013 10-K 2015-03-13
Q2 2013 $68.5M $18.2M +$2.22M +13.9% Mar 30, 2013 Jun 28, 2013 10-K 2014-03-12
Q1 2013 $66.3M $18M +$2.49M +16.1% Dec 29, 2012 Mar 29, 2013 10-K 2014-03-12
Q4 2012 $63.8M $16.5M +$85K +0.52% Sep 29, 2012 Dec 28, 2012 10-K 2014-03-12
Q3 2012 $63.7M $15.9M +$600K +3.93% Jun 30, 2012 Sep 28, 2012 10-K 2014-03-12
Q2 2012 $63.1M $15.9M -$327K -2.01% Mar 31, 2012 Jun 29, 2012 10-K 2014-03-12
Q1 2012 $63.4M $15.5M +$660K +4.45% Dec 31, 2011 Mar 30, 2012 10-K 2014-03-12
Q4 2011 $62.8M $16.4M Oct 1, 2011 Dec 30, 2011 10-K 2013-03-12
Q3 2011 $15.3M Jul 2, 2011 Sep 30, 2011 10-K 2013-03-12
Q2 2011 $16.3M Apr 2, 2011 Jul 1, 2011 10-K 2013-03-12
Q1 2011 $14.8M Jan 1, 2011 Apr 1, 2011 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.